Broadwood partners publishes presentation detailing opposition to staar surgical's sale to alcon

New york--(business wire)--broadwood partners, l.p. and its affiliates (collectively, “broadwood”), holders of approximately 27.5% of the outstanding common stock of staar surgical company (“staar” or the “company”) (nasdaq: staa), today announced that it has published a presentation outlining why stockholders should vote on broadwood's green proxy card “against” the proposed acquisition of the company by an affiliate of alcon inc. (nyse: alc) on the terms announced on august 5, 2025. the 81-pa.
ALC Ratings Summary
ALC Quant Ranking